Navigation Links
Elsevier launches new open access journal: Translational Proteomics
Date:5/28/2013

Geneva, Switzerland, May 27, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Translational Proteomics, an online-only, open access journal devoted to transferring fundamental discoveries in the field of proteomics to clinical applications, accelerating understanding and treatment of human diseases.

Jean-Charles Sanchez, Associate Professor at the University of Geneva, Head of the Biomedical Research Proteomics Group and Director of the Proteomics Core Facility of the Faculty of Medicine, will serve as Editor-in-Chief. The journal aims to cover all areas of research in human proteomics using multi-disciplinary approaches to untangle complex disease processes, such as oncology, neurology, immunology, cardiovascular diseases, infectious diseases and any internal medical disorder. Special sections within the journal will highlight research in areas like systems biology and integrative bioinformatics, clinical proteomics and personalized medicine, comparative proteomics and drug development, medical bioinformatics and biostatistics, food and health.

"With the launch of Translational Proteomics, we want to help the scientific and medical communities overcome the challenges they face on the long path from basic research to patient care," said Professor Sanchez. "By focusing on connecting basic proteomics research to ultimate clinical applications, the journal will provide a space for publications detailing proteomics experiments, from early discovery to validation and the bedside."

"We are excited about the launch of Translational Proteomics", added Dolors Alsina, Executive Publisher at Elsevier. "This journal provides a unique platform for the publication of high-quality, multi-disciplinary studies, combining research which, until now, would have been broken into two or more specialized publications."


'/>"/>

Contact: Kristian Wilson
k.wilson@elsevier.com
44-018-658-43817
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
2. Elsevier announces the launch of a new journal: Wound Medicine
3. Elsevier announces the launch of a new journal: Methods in Oceanography
4. Elsevier wins 6 PROSE Awards
5. Elsevier announces the launch of a new journal: Journal of Forensic Radiology and Imaging
6. Elsevier announces the launch of a new journal: Anthropocene
7. Elsevier launches new open access journal: Molecular Metabolism
8. Elsevier launches new journal: Journal of Unconventional Oil and Gas Resources
9. Elsevier launches new open access journal -- Case Studies in Engineering Failure Analysis
10. 2012 Reed Elsevier Environmental Challenge winners announced
11. Elsevier launches new open access journal: Applied and Translational Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: